臨床婦人科産科68巻11号

2014年11月発行

今月の臨床 妊娠高血圧症候群のベストマネジメント

管理と治療

3．高血圧症合併妊娠と加重型妊娠高血圧腎症の管理

著者： 田中幹二¹ 大石舞香¹ 千葉仁美¹

所属機関： ¹弘前大学医学部附属病院周産母子センター

ページ範囲：P.1097 - P.1103

文献概要

●高血圧合併妊娠では，臓器障害を伴う軽症高血圧や重症高血圧の場合に降圧薬投与を考慮する．

●母児病態の増悪がみられず降圧目標が維持できていれば，37週以降まで妊娠継続を図ってよい．

●臓器障害を伴う軽症高血圧や重症高血圧では，少なくとも分娩後48時間は厳重な血圧管理を行う．

●産後は，長期予後の観点から内科と連携したうえでの血圧，降圧薬の再評価が勧められる．

参考文献

1） Lindheimer MD, et al : Hypertension in pregnancy. J Am Soc Hypertens 4 : 68─78, 2010

2） Magee LA, et al : Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Clinical Practice Guideline No. 206. Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can 30（3 Sappl） : S1─S48, 2008

3） Lowe SA, et al : Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49 : 242─246, 2009

4） Hypertension in pregnancy : the management of hypertensive disorders during pregnancy. NICE Clinical Guideline 107. the National Institute for Health and Clinical Excellence. NICE, London, 2010

5） Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 : S1─S22, 2000

6） Lawler, et al : Population-based analysis of hypertensive disorders in pregnancy. Hypertens Pregnancy 26 : 67─76, 2007

7） Sibai BM : Chronic hypertension in pregnancy. Obstet Gynecol 100 : 369─377, 2002

8） 日本高血圧学会高血圧治療ガイドライン作成委員会 : 高血圧治療ガイドライン2014．ライフサイエンス出版，2014

9） Gilbert WM, et al : Pregnancy outcomes in women with chronic hypertension : a population-based study. J Reprod Med 52 : 1046─1051, 2007

10） Sibai BM, et al : Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Eng J Med 339 : 667─671, 1998

11） Zetterstrom K, et al : Maternal complications in women with chronic hypertension : a population-based cohort study. Acta Obstet Gynecol Scand 84 : 419─424, 2005

12） Vigil-De Gracia P, et al : Perinatal outcome in women with severe chronic hypertension during the second half of pregnancy. Int J Gynaecol Obstet 85 : 139─144, 2004

13） Ananth CV, et al : Chronic hypertension and risk of placental abruption. Am J Obste Gynecol 197 : 273. e1─7, 2007

14） Vanek M, et al : Chronic hypertension and the risk for adverse pregnancy outcome after superimposed preeclampsia. Int J Gynaecol Obstet 86 : 7─11, 2004

15） Ono Y, et al : Neonatal outcome in infants of chronically hypertensive mothers. JOGR 39 : 1142─1146, 2013

16） Zetterstrom K, et al : Chronic hypertension as a risk factor for offspring to be born small for gestational age. Acta Obstet Gynecol Scand 85 : 1046─1050, 2006

17） Allen VM, et al : The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth : a population based study. BMC Pregnancy Childbirth 4 : 17, 2004

18） Magee LA, et al : How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 72 : 394─401, 2011

19） Abalos E, et al : Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Chchrane Datebase Sys Rev（1） : CD002252, 2007

20） Sibai BM, et al : A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162 : 960─966, 1990

21） von Dadelszen P, et al : Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension : an updated metaregression analysis. J obstet Gynecol Can 24 : 941─945, 2002

22） Duley L, et al : Management of pre-eclampsia. BMJ 332 : 463─468, 2006

23） Magee L, et al : Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev（3） : CD002863, 2003

24） Working group report on high blood pressure in pregnancy. National Institute of health. NIH publication NO 00─3029, 2000

25） Jones DC, et al : Outcome of pregnancy in women moderate or severe renal insufficiency. N Eng J Med 335 : 226─232, 1996

26） Montan S, et al : Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 168 : 152─156, 1993

27） Ounsted M, et al : Maternal hypertension with superimposed pre-eclampsia : effects on child development at 7 1/2 years. Br J Obstet Gynaecol 90 : 644─649, 1983

28） Magee LA, et al : Hydralazine for treatment of severe hypertension in pregnancy : meta-analysis. BMJ 327 : 955─960, 2003

29） Ohman KP, et al : Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension. Eur J Clin Phamacol 29 : 149─154, 1985

30） Koch G, et al : Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease. Int J Cardiol 25 : 73─79, 1989

31） Emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Committee Opinion No. 514. American College of Obstetricians and Gynecologists. Obstet Gynecol 118 : 1465─1468, 2011

32） Duley L, et al : Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev（3） : CD001449. pub2, 2006

33） Barr M Jr, et al : ACE inhibitor fetopathy and hypocalvaria : the kidney-skull connection. Teratology 44 : 485─495, 1991

34） Briggs GG, et al : Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk. 9th ed. Wolters Kluwer／Lippincott Williams＆Wilkins, 2011

35） Buttar HS : An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176 : 61─71, 1997

36） Pryde PG, et al : Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 9 : 1575─1582, 1993

37） Cooper WO, et al : Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 : 2443─2451, 2006

38） Bos-Thompson MA, et al : Fetal toxic effects of angiotensin II receptor antagonists : case report and follow-up after birth. Ann Pharmacother 39 : 157─161, 2005

39） Serreau R, et al : Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy : a report of 10 cases. BJOG 112 : 710─712, 2005

40） Diav-Citrin O, et al : Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol 31 : 540─545, 2011

41） Li DK, et al : Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring : a retrospective cohort study. BMJ 343 : d5931, 2011

42） American Congress of Obstetricians and Gynecologists : Hypertension in pregnancy : ACOG Task force, 2013

43） Magee LA, et al : Fortnightly review : manage-ment of hypertension in pregnancy. BMJ 318 : 1332─1336, 1999

44） Redman CW, et al : Treatment of hypertension in pregnancy with methyldopa : blood pressure control and side effects. BJOG 84 : 419─426, 1977

45） von Dadelszen P, et al : Antihypertensive medications in the management of gestational hypertension─Preeclampsia. Clin Obstet Gynecol 48 : 441─458, 2005

46） Watanabe K, et al : Outline of definition and classification of Pregnancy induced Hypertension. Hypertens Res Preg 1 : 3─4, 2013

47） Cote AM, et al : Diagnostic accuracy of urinary spotprotein : creatinine ratio for proteinuria in hyperten-sive pregnant women : systematic review. BMJ 336 : 1003─1006, 2008

48） Cote AM, et al : The 24-hour urine collection : gold standard or historical practice? Am J Obstet Gynecol 199 : 625. e1─6, 2008

49） Steegers EA, et al : Preeclampsia. Lancet 376 : 631─644, 2010

50） Rey E, et al : The progonosisi of pregnancy in women with chironic hypertension. Am J Obstet Gynecol 171 : 410─416, 1994